Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1…
This clinical study is the first from Merck and Gilead’s collaboration to develop potential long-acting HIV treatment options
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
clinical studies
Clinical Data Standards in the era of AI, ML and digital transformation
Shrishaila Patil, VP, Statistical Programming, Navitas Data Sciences, a part of Navitas Life Sciences (a TAKE Solutions…
UK strikes deal with GSK and Sanofi for 60 mn doses of COVID-19 vaccine
The British government said the latest deal helps grow the country’s portfolio of vaccine candidates and adds to previous…